• support@madhedgefundtrader.com
  • Biotech Model Portfolio
  • Daily Hot Tips
  • Hot Tips Archive
  • Member Login
  • Logout
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • My Account
    • Global Trading Dispatch
    • Mad Hedge Technology Letter
    • Biotech Newsletter
    • Newsletter
    • Mad Options Trader
    • Mad Hedge AI
    • Jacquie’s Post
    • Free Newsletter / Hot Tips
    • My Profile
      • Update Password
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

The Eyewear Pivot Nobody Saw Coming

Tech Letter

Meta (META) migration into the eyewear business is a little bit of a head scratcher until peeling back the layers and really understanding what is going on.

EssilorLuxottica’s agreement to prolong its long-term collaboration with Meta Platforms for the development of smart eyewear over the upcoming 10 years is a massive victory for Meta CEO Mark Zuckerberg.

This milestone offers meaningful insight into the direction of where the business model is heading.

Many have expected that Meta would start to branch out into other venues once their core businesses start to stagnate.

The digital ad game and social media platforms only go so far in terms of growth these days, and shareholders are waiting on the next big thing.

Short-term prospects are what drives the stock movement, and Meta is looking for that pixie dust.

EssilorLuxottica is the largest maker of eyewear in the world and the owner of many eyewear brands and retailers, including Ray-Ban, LensCrafters, and Pearle Vision in the U.S.

EssilorLuxottica also acquired Heidelberg Engineering, maker of imaging and healthcare machinery and technology, largely for the ophthalmic and eyecare markets worldwide.

Prescription glasses are not cheap, ranging into the thousands of dollars for designer frames and lenses.

If Meta can figure out how to do this all online without going to the optician, imagine the juicy margins they could extract from this sort of venture.

Meta and EssilorLuxottica have a relationship for the production of the Ray-Ban smart glasses. The glasses’ latest version gives consumers video, camera, and Bluetooth headset capability in a stylish eyewear frame with a cool brand on it.

Heidelberg Engineering makes complex, sophisticated, expensive equipment that you may be exposed to if you’re examined in an ophthalmologist’s office. Buying Heidelberg makes EssilorLuxottica more entrenched in the industry, where it is the established leader.

The tie-up with EssilorLuxottica is the perfect onboarding situation to understand how to perfect the optimal glasses and lenses, and then to transfer it into an online experience.

Remember, even if this investment is for VR purposes, the application revolves around virtual eyewear as well.

Meta now understands they need to secure a monopoly on eyewear, and it is a conscious decision to make that a launching point into more of their products.

In the future, Meta wants consumers to access Instagram, WhatsApp, and Facebook through EssilorLuxottica eyewear products.

Meta also hopes to secure the first mover advantage while other big tech firms lack the deep knowledge of eyewear. There have already been numerous failed attempts at smart glasses, and so Meta founder Mark Zuckerberg is doubling down with a relationship with Europe’s most deeply entrenched premium eyewear firm.

Although the boost to the bottom and top line won’t happen quickly with a possible relationship with EssilorLuxottica, this could anoint Meta as the gatekeepers to the new virtual world through this new eyewear tech.

It’s becoming clear that Meta is running up to certain upper limits in regards to growth of their 3 platforms, and they are looking for another super booster to prop up profits.

Meta has never been shy at poaching outside talent and rewarding them handsomely.

On the flip side, EssilorLuxottica would be smart to adopt some tech now by hiring the right people and trying to digitize the experience further, otherwise Meta will get what they are coming for.

Meta pushing the envelope is one of the big reasons why they have stayed ahead of other big tech companies and why the stock has done so well over the past few years.

Meta stock is a great short-term and long-term proposition for patient and impatient investors.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 14:02:492025-07-18 14:50:56The Eyewear Pivot Nobody Saw Coming
Mad Hedge Fund Trader

July 18, 2025 – Quote of the Day

Tech Letter

“If you can’t make it good, at least make it look good.” – Said American Bill Gates

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/10/bill-gates-1.png 542 438 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2025-07-18 14:00:472025-07-18 14:48:36July 18, 2025 – Quote of the Day
april@madhedgefundtrader.com

Trade Alert – (AMGN) July 18, 2025 – EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 13:19:332025-07-18 13:19:33Trade Alert – (AMGN) July 18, 2025 – EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

July 18, 2025

Jacque's Post

 

(SUMMARY OF JOHN’S JULY 16, 2025, WEBINAR)

 

July 18, 2025

Hello everyone

 

TITLE

Uncertainty Rules

 

TRADE ALERT PERFORMANCE

MTD: +2.59%

2025 YTD: +47.76%

Trailing One Year Return: +100.45%

Average Annualised Return: +51.30%

Since inception: +799.65%

 

PORTFOLIO REVIEW

Risk On

(AMGN) 7/$260-$270 call spread

Risk Off

(TSLA) 7/$360-$370 put spread (closed & profits taken)

(TSLA) 7/$420-$430 put spread

 

THE METHOD TO MY MADNESS

Stocks are now at very high-risk levels due to an increasingly unstable world.

John says, AI is the big leader, but the risk/reward here is terrible.

Bonds approaching 2025 lows, yields new highs.

The new budget bill passed a $5 trillion debt ceiling increase.

Safety assets like gold, silver, and T-bills are flat lining with crypto bleeding off speculative capital.

Oil is still dead-on recession fears and OPEC market share battle

US Dollar hits new four-year lows.

Bitcoin hits new all-time high at $123k.

 

THE GLOBAL ECONOMY – DEFLATING

The June Nonfarm Payroll wasn’t so hot.

Half of the 147,000 gains were government jobs, and only 74,000 were from the private sector, a quarter of what they were a year ago.

The Headline Unemployment Rate dropped 0.1% to 4.1%.

Some 590,000 full-time jobs have been lost since the beginning of 2025.

Immigration Crackdown to cut US GDP by 1.0% according to a Federal Reserve study.

The Port of Los Angeles sees an Import surge.

Clothing Imports from China hit 22-year low.

Used Car Prices surge as still tariffs drive imported car prices through the roof.

 

STOCKS – TOPPING OUT

Historic market concentration bodes ill for future gains.

Since 1972, the S&P 500 has posted below-average returns over the next one, three, six, and 12 months when new records were made with fewer than 100 stocks.

Bitcoin plays take off on new highs.

Hedge Fund Citadel buys Morgan Stanley’s Option Business.

US Military becomes the largest shareholder in MP Materials, the largest producer of rare earths in the US.

Italy buys US Corn Flakes; Ferrero International SA is close to acquiring WK Kellogg Co. for about $3 billion.

Boeing ramps up 737 production, delivering 60 airplanes last month, the most since December 2023.

Constellation was wiped out by tariffs on Aluminium.

 

BONDS PARIAHS

Budget bill raises debt ceiling by $5 trillion.

John says we could get there by the end of 2026.

Bonds hate the national debt at $42 trillion and are approaching 2025 lows in prices, highs in yields.

Long-term U.S. bonds have become pariahs.

Bond investors are moving away from longer-dated Treasuries.

The Bond Vigilantes are back and are not to be taken lightly.

Government spending hit a new all-time high in May.  Increased spending on Homeland Security is the cause.

Avoid (TLT), (JNK), (NLY), (SLRN), and REITS.

 

FOREIGN CURRENCIES – NO DOLLAR FRIENDS

US dollar hits four-year low, as the “Sell America” trade continues.

Short dollars against long Euros – it’s become the most concentrated trade in global markets.

It’s almost unprecedented for a currency to fall when its interest rates are rising.

Debt, default, and trade wars are now the larger concern.

Next dollar weakness will come with evidence of a recession in days.

Buy (FXA), (FXE), (FXB), (FXC), and (FXY)

 

ENERGY & COMMODITIES

The Energy Sector is marking down earnings.

Exxon (XOM), the biggest U.S. energy company, was rising in early trading even after it flagged that second-quarter earnings will take a hit from lower energy prices.

US drillers cut rigs for 10th week, or the first time since July 2020, thanks to a global oil glut.

OPEC increases production by 550,000 barrels a day.

Budget bill kills effort to restore strategic petroleum reserve, cutting the funding by 90%.

US Crude inventories hit one one-year low.

Look for energy plays to hit new lows.

Copper hits new all-time high on 50% tariff.

 

PRECIOUS METALS – CONSOLIDATING

Bitcoin breakout is stealing gold’s thunder.

Speculative money is chasing new highs in crypto plays at the expense of gold.

Traders have been rolling out of hedges as stocks rise.

Silver hits a new high for the year.

(AGQ) 2X LEAPS hit max profit.

$50 silver is a long-term target.

John’s target for gold is $5,000.

 

REAL ESTATE – NO BUYERS

Housing starts hit five-year low.

Multifamily dropped 30% MOM as a record supply hits the market.

Single-family home starts fell 7% YOY.

All housing-related stats are falling off a cliff.

Homebuilder Sentiment hits pandemic low.

Watch the homebuilders as they will front-run any fall in interest rates in 2026.

Apartment rents are slowing, up only 0.4% in May and down 0.5% YOY, usually a strong period.

 

TRADE SHEET

Stocks – stand aside

Bonds – sell rallies

Commodities – buy dips

Currencies – buy dips

Precious Metals – buy dips

Energy – stand aside

Volatility – sell over $30

Real Estate – stand aside

 

NEXT STRATEGY WEBINAR

12:00 EST Wednesday, July 30, 2025

From Incline Village, NV.

 

Cheers

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 12:00:172025-07-18 12:28:38July 18, 2025
april@madhedgefundtrader.com

Trade Alert – (NFLX) July 18, 2025 – BUY

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 11:45:422025-07-18 11:45:42Trade Alert – (NFLX) July 18, 2025 – BUY
april@madhedgefundtrader.com

July 18, 2025

Diary, Newsletter, Summary

Global Market Comments
July 18, 2025
Fiat Lux

 

Featured Trade:

(JULY 16 BIWEEKLY STRATEGY WEBINAR Q&A),
(GLD), (SLV), (DHI), (LEN), (CCI), (KRE), (META), (NFLX), (AMZN), (SLB), (PPL), (XOM), (OXY), (AGQ), (WFC), (DXJ), (FXE)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 09:04:562025-07-18 14:43:34July 18, 2025
april@madhedgefundtrader.com

July 16 Biweekly Strategy Webinar Q&A

Diary, Homepage Posts, Newsletter

Below, please find subscribers’ Q&A for the July 16 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Incline Village, NV.

Q: Is gold (GLD) dead, or is it just resting?

A: It is just making a pit stop on the way to $5,000 an ounce. It’s currently around $3,365 an ounce and is moving sideways. This is often what you get: in the middle of a long-term bull trend, you get a long sideways move. But nobody really wants to sell, and what’s happening is that the upside breakout in Bitcoin to new heights is drawing speculative money out of the precious metals markets into crypto plays, of which there are dozens of now. They’ve all had tremendous moves. So, gold will resume, probably when the stock market starts to go down, which could be any day.

Q: What is your upside target for silver (SLV)?

A: Well, silver broke out and did hit a new high for the year last week. What buying is happening in precious metals is rotating out of gold into silver. The ProShares Ultra Silver ETF (AGQ), which was a LEAPS we put out a year ago, is now at max profit, so if you have that position, go ahead and take your profit. I think it’s 140% profit instead of hanging on till January when it expires.

Q: With the big, beautiful bill increasing government spending and debt, are we primed for runaway inflation?

A: The answer is yes, we are. But it may take months for the markets to realize that. The thing with international trade is it takes a long time for effects to be felt, because goods have to be loaded on ships to cross the ocean, clear customs, get loaded on trucks, and moved to the stores. What companies are doing is they’re using up existing inventories at old prices before they start passing on the new, higher prices. If you go into a Subaru dealer right now, they are offering pre-tariff prices. Once they run out of inventory, the price of a Subaru rises from $30,000 to $40,000. So that shows you what’s coming our way. That is a big increase, and we’re expecting a lot of big increases. And of course, the government is trying to hide the inflation by firing three-quarters of the Bureau of Labor Statistics staff, which means they have cut the number of data points they’re collecting by 75%. And guess which ones they cut? Chinese imports because those are showing the biggest price increases. So, all government inflation data from here on can be viewed as corrupted and artificially low. If you don’t believe me, The Economist magazine in London did an excellent piece on exactly what’s happening there. And that is happening not just with inflation data, but with all other economic data as well. It’s all being trashed, wiped out from government websites, and so on.

Q: What are the best interest rate plays out there if the Fed lowers interest rates?

A: Home builders like DR Horton Inc (DHI) and Lennar Corporation (LEN), REITs like Crown Castle International (CCI), and regional banks like the SPDR S&P Regional Banking ETF (KRE). You might say small caps, but half of all small caps are banks. They’re regional banks, so the better way to go there is just buy the regional banks, and you should get serious moves on this if we do get our 300 basis points in rate cuts.

Q: What are the best tech stocks to buy on the next dip?

A: All of the AI leaders, so that would be NVIDIA (NVDA), Meta Platforms Incorporated (META), Netflix (NFLX), and Amazon (AMZN).

Q: Stocks like Schlumberger (SLB) and PPL Corp. (PPL) are showing good value. When is it time to buy?

A: Right before an economic recovery (and not just a U.S. Recovery, but a global recovery) is when the demand for oil increases, and that’s when the energy plays start to kick in again. Right now, we’re still having a price war at OPEC, so it’s a no touch.

Q: How do you suppose the fuel switch got turned off on the Boeing aircraft and the India crash?

A: Poor training. And notice that all these Boeing crashes are happening in emerging countries, where you can get a commercial pilot’s license with only 200 hours of flight time, as opposed to 1,200 hours in the U.S. and 800 hours in Europe. All you have to do is flip the wrong switch, and your engine shuts off. But the plane still should have been able to keep climbing on one engine, which means the plane was overloaded because it crashed on one engine. I’ve gotten every FAA crash report for the last 50 years, and they all have the same things in common: You get not one error, but a multiplicity of errors that compound and lead to these catastrophic crashes. Having been in three plane crashes myself, I’m something of an expert on the subject (Paris, Palermo, and Austria).

Q: What oil stocks do we buy on an economic recovery? When will it happen, if it happens?

A: If the trade war doesn’t end, there is no recovery for a start. If it does end, you will get a recovery. And you would go after Occidental Petroleum (OXY), and ExxonMobil (XOM) for the dividend, which is currently at 3.67%. You know, at some point, people are going to look for cheap stocks, and oil—along with pharmaceuticals and home builders—are among the cheapest stocks in the market right now.

Q: What is your favorite big bank right now?

A: That’s a good question. I’m buying Wells Fargo (WFC) because they’re the cheapest large bank in the market. This is because, for the last decade, they’ve been the most set back by an endless series of fines from the SEC and the FCC for their dubious business practices. They also faced capital restrictions. Getting caught stealing from churches because they were too dumb to notice is not good for business, and it’s terrible for the share price. However, the new management is now in place, and a turnaround is underway. Administration has lifted the remaining restrictions and forgiven any remaining fines as a deregulation play. Little known is that Wells Fargo is also the fifth largest buyer of their own stock in the country; they have a $40 billion budget to buy back their own shares. Wells also has a decent implied volatility on the options at 40%, and I’ll probably put out a trade alert as soon as the stock stops going down. It is up on the day after a sell-off, so I will be watching this space.

Q: Should I take profits in silver? The ProShares Ultra Silver ETF (AGQ) hit 55 last week.

A: If you have the LEAPS, yes, free up the capital. You’re at 90% of max profit, so roll it into another trade. However, long-term silver holders, hang on, I think we’re headed for the old high of $50, which we haven’t seen since the Bunker Hunt short squeeze in 1979.

Q: What would happen if Jay Powell got fired?

A: You might get an immediate rally in the bond market, and after that, they’ll crash, because that means a superheated economy and extremely high inflation, which will be almost impossible to get rid of.

Q: What is the number one contrarian play in the market right now?

A: That would be to buy dollars, the WisdomTree Japan Hedged Equity Fund (DXJ), and sell short euros (FXE) against it. It’s the most overweight trade in the world right now. We could get a reversal at any time, and it could be big, since the positions are so one-sided. It’s the lopsided classic—too many people at one end of the canoe-type trade.

To watch a replay of this webinar with all the charts, bells, whistles, and classic rock music, just log in to www.madhedgefundtrader.com, go to MY ACCOUNT, click on GLOBAL TRADING DISPATCH, TECHNOLOGY LETTER, JACQUIE’S POST, then WEBINARS, and all the webinars from the last 12 years are there in all their glory.

Good Luck and Good Trading,

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

My Old Jeep at the Atomic Energy Commission

 

 

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2024/10/old-jeep.png 822 1096 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-18 09:02:162025-07-18 14:41:41July 16 Biweekly Strategy Webinar Q&A
Mad Hedge Fund Trader

July 18, 2025 – Quote of the Day

Diary, Newsletter, Quote of the Day

“The investor in America sits at the bottom of the food chain,” said John C. Bogle, founder of the Vanguard Group of index funds.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2012/04/LION.jpg 301 320 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2025-07-18 09:00:112025-07-18 14:41:02July 18, 2025 – Quote of the Day
april@madhedgefundtrader.com

July 17, 2025

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
July 17, 2025
Fiat Lux

 

Featured Trade:

(BIOTECH’S GRAY FOX)

(AMGN), (ABBV), (PFE), (REGN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-17 12:02:262025-07-17 12:15:52July 17, 2025
april@madhedgefundtrader.com

Biotech’s Gray Fox

Biotech Letter

Every investor has a stock they own, not for the adrenaline rush but for the steady hand it provides. Years ago, that meant a ladder of Treasuries and a bottle of Tums. Today, it might just be Amgen (AMGN).

You won’t find it trending on Reddit or being whispered about in hedge fund chatrooms. It’s not running on AI hype or meme magic.

Instead, what you will find is a dependable biotech veteran with a strong dividend, a rock-solid balance sheet, and a quietly impressive pipeline that’s starting to show some real muscle.

After a modest pullback, Amgen looks more attractive than it has in some time.

At first glance, it looks like a mature drugmaker doing what mature drugmakers do: collect royalty checks, keep the dividend stable, and try not to screw up.

But the story under the surface is getting more interesting. There’s real optionality here, and the market isn’t fully pricing it in.

And after a 12% dip from the highs, you’re getting paid to look closer.

Let’s start with Horizon Therapeutics. The acquisition caught some flak. Analysts grumbled about the price tag. Regulators kicked the tires.

But here we are, and Horizon’s drugs, Tepezza and Krystexxa, are settling in just fine.

Amgen didn’t buy hype. It bought cash flows. And given the early returns, it may have paid less than it looks.

Then there’s biosimilars. For years, they were treated like biotech’s version of knockoff handbags: low prestige, thin margins, more trouble than they’re worth. But Amgen saw the long game.

With Amjevita now in the US market gunning for Humira, it’s not about prestige, it’s about volume and execution. This has now stopped being a side hustle but a new and sustainable business line.

The pipeline, meanwhile, is quietly moving.

Tarlatamab for small cell lung cancer isn’t just a science experiment. It’s a T-cell engager with real data and serious upside. Olpasiran in cardiovascular disease? A potential blockbuster in the making.

These aren’t blue-sky R&D. These are real stuff with clear paths to approval. And it doesn’t hurt that Amgen knows how to get drugs through the FDA without a parade of surprises.

Now, put Amgen next to the usual suspects.

AbbVie (ABBV) still leans heavily on Skyrizi and Rinvoq to patch the Humira hole, and the market’s still waiting for proof.

Pfizer (PFE) is wandering through the COVID hangover, unsure of what it wants to be when it grows up.

Amgen, by contrast, is paying a 3.4% yield, raising that payout annually, and generating $11 billion in free cash flow. It’s not a turnaround story. It’s a continuation of competence.

And here’s the kicker. Despite all this, the stock has pulled back. Not because of a missed quarter or bad data, but because biotech fell out of favor.

No headlines. No blowups. Just a valuation gap waiting for someone to notice.

That kind of disconnect reminds me of a trade I made years ago in Regeneron (REGN). The market had written it off. Too mature, too slow, too quiet.

But under the surface, the pipeline was humming. Optionality was there – you just had to know where to look. That position ended up outperforming expectations by miles, not because I caught lightning in a bottle, but because the market mispriced quiet competence.

Amgen sits in that same zone today. It’s not a party stock. It doesn’t need to be. It’s the kind of name you own because you like getting paid while management does its job.

It’s not a moonshot, but it’s not priced like one either. And if even half of the pipeline delivers, this stock could quietly rerate before most people notice what changed.

If you believe that real value still matters in a market crowded with noise, Amgen is worth your time. It’s yielding, compounding, and positioning itself for another chapter of relevance. No gimmicks, no theatrics, just serious business in a space that rewards it.

And if that sounds too boring for some, well, they can keep chasing the next shiny thing. I’ll take a company that pays me to wait…especially when there’s something worth waiting for.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-07-17 12:00:312025-07-17 12:14:48Biotech’s Gray Fox
Page 7 of 16«‹56789›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top